HomeClinical Trials, Studies, Data Updates

Clinical Trials, Studies, Data Updates

Multi-Beat Analysis Algorithm New Study Further Confirms Superior Accuracy in Comparison to a Competing Option

The study compared the accuracy of two cardiac output monitors, the Retia Argos and the Edwards Lifesciences FloTrac across 58 patients undergoing off-pump coronary artery bypass surgery, yielding 572 sets of cardiac output measurements from each device.

Aerin Medical Announces Results of Randomized Controlled Trial Supporting VivAer® for Treatment of Nasal Airway Obstruction With Nasal Valve Collapse

Treatment with VivAer, a non-invasive, temperature-controlled, radiofrequency (RF) device, resulted in significant symptom relief, superior to sham control.

IntraOp Medical Announces First Patients Enrolled in FLASH Clinical Trial

Impulse Trial is the first to evaluate the curative potential of the FLASH Effect

BioSig Technologies Announces PURE-EP System Clinical Data

PURE EP System is designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals during complex ablation procedures.

Surfacide Peer-Reviewed Study: Confirms UV-C Extremely Effective in Killing SARS-CoV-2 On Surfaces and Air in Environments

The study was led by Dr. Randy Loftus, MD, an Associate Professor of Anesthesiology and Critical Care Medicine at University of Iowa Hospital and Clinics, and Dr. Franklin Dexter, MD, PhD, University of Iowa Professor in the Department of Anesthesia.

CarThera Reports Preclinical Results in the Testing of the Combination of SonoCloud® Technology with Immunotherapies

The goal of the preclinical work was to investigate the following: to see if low-intensity pulsed ultrasound could enhance the therapeutic efficacy of anti-PD-1 in C57BL/6 mice – bearing intracranial GL261 gliomas; epidermal growth factor receptor variant III (EGFRvIII) specific chimeric antigen receptor (CAR) T cells within NSG mice with established EGFRvIII-U87 gliomas (epidermal growth factor receptor variant III); and a genetically-engineered antigen-presenting cells (APC)-based therapy, producing the T-cell attracting chemokine CXCL10 in the GL261-bearing mice

HistoSonics Announces First Patient Treated in European Clinical Trial

Otto von Guericke University Clinic Magdeburg is first to treat patient with liver tumors in company's #HOPE4LIVER Europe Study

Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier®

Both patients were given access to Hemopurifier® treatment through Emergency Use. The manuscript is titled "Removal of COVID-19 Spike Protein, Whole Virus, Exosomes and Exosomal microRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients with COVID-19 Infection" and was published in Research Square.

IRRAS Announces Publication of a Case Report from Buffalo General Medical Center

IRRAflow Intraventricular Hemorrhage (IVH) Case Report Published in Cureus Journal of Medical Science. Publication also documents the ability to deliver targeted thrombolytic medication via IRRAflow's recurring irrigation for the first time in the peer-reviewed scientific literature

FAST BioMedical Successfully Completes Open-Label Proof-of-Concept Study for Measuring Interstitial Volume

Conducted at the Richard L. Roudebush VA Medical Center in Indianapolis, the study evaluated the safety, tolerability and performance of the FAST Technology in chronic dialysis patients with extremely reduced or no kidney function.

By using this website you agree to accept Medical Device News Magazine Privacy Policy